Literature DB >> 16689668

Augmented locomotor recovery after spinal cord injury in the athymic nude rat.

Jason R Potas1, Yu Zheng, Charbel Moussa, Melinda Venn, Catherine A Gorrie, Chao Deng, Phil M E Waite.   

Abstract

The immune response contributes to ongoing secondary tissue destruction following spinal cord injury (SCI). Although infiltrating neutrophils and monocytes have been well studied in this process, T-cells have received less attention. The objective of this study was to assess locomotor recovery and tissue morphology after SCI in athymic (nude) rats, in which T-cell numbers are reduced. Results in athymic rats were compared with heterozygote littermates with normal T-cell profiles and with Sprague-Dawley rats from previous studies in our lab. Following transection of rat spinal cords at T10, we assessed the animals' locomotor recovery on a weekly basis for up to 11 weeks, using the Basso-Beattie-Bresnahan locomotor rating scale. Nude rats showed better locomotor recovery than did heterozygote or Sprague-Dawley rats, achieving scores of 5.6 +/- 0.8 versus 1.0 +/- 0.0, respectively (p = 0.002), at 4 weeks postinjury. The improved recovery of nude rats persisted for the 11-week postinjury assessment period, and was consistent with improved spinal reflexes rather than with recovery of descending motor pathways. Anatomical evaluation at 11 weeks indicated no difference in nude versus heterozygote rats in the size or distribution of cavities caudal to the transection site, but secondary damage was more severe rostral to the transection site in heterozygote rats. In neither group did cavities extend beyond 4 mm caudal to the transection site, and were therefore not directly responsible for the functional differences between the two groups. Cellular expression of the microglia/macrophage antigen ectodysplasin A (ED1) was reduced in nude rats as compared to heterozygotes, but no difference was observed in expression levels of 5-hydroxytryptamine, the 200-kDa neurofilament, or glial fibrillary acidic protein. The findings of the study show that a reduction in T-cell numbers significantly improves locomotor recovery after spinal cord transection, indicating a deleterious role for these immune cells in neural repair after trauma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16689668     DOI: 10.1089/neu.2006.23.660

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  16 in total

Review 1.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

Review 2.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

3.  Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury.

Authors:  Ying Jin; Birgit Neuhuber; Anita Singh; Julien Bouyer; Angelo Lepore; Joseph Bonner; Tim Himes; James T Campanelli; Itzhak Fischer
Journal:  J Neurotrauma       Date:  2011-03-24       Impact factor: 5.269

4.  The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice.

Authors:  Hongbo Li; Weimin Kong; Christina R Chambers; Daohai Yu; Doina Ganea; Ronald F Tuma; Sara Jane Ward
Journal:  Cell Immunol       Date:  2018-03-08       Impact factor: 4.868

5.  Traumatic spinal cord injury in mice with human immune systems.

Authors:  Randall S Carpenter; Kristina A Kigerl; Jessica M Marbourg; Andrew D Gaudet; Devra Huey; Stefan Niewiesk; Phillip G Popovich
Journal:  Exp Neurol       Date:  2015-07-17       Impact factor: 5.330

6.  FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.

Authors:  Kangmin D Lee; Woon N Chow; Carmen Sato-Bigbee; Martin R Graf; Robert S Graham; Raymond J Colello; Harold F Young; Bruce E Mathern
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

7.  Safety of human neural stem cell transplantation in chronic spinal cord injury.

Authors:  Katja M Piltti; Desiree L Salazar; Nobuko Uchida; Brian J Cummings; Aileen J Anderson
Journal:  Stem Cells Transl Med       Date:  2013-11-04       Impact factor: 6.940

8.  Early Immunomodulation by Intravenously Transplanted Mesenchymal Stem Cells Promotes Functional Recovery in Spinal Cord Injured Rats.

Authors:  Jung Hwa Seo; In Keun Jang; Hyongbum Kim; Mal Sook Yang; Jong Eun Lee; Hyo Eun Kim; Yong-Woo Eom; Doo-Hoon Lee; Ji Hea Yu; Ji Yeon Kim; Hyun Ok Kim; Sung-Rae Cho
Journal:  Cell Med       Date:  2011-10-01

9.  Adoptive transfer of Th1-conditioned lymphocytes promotes axonal remodeling and functional recovery after spinal cord injury.

Authors:  H Ishii; X Jin; M Ueno; S Tanabe; T Kubo; S Serada; T Naka; T Yamashita
Journal:  Cell Death Dis       Date:  2012-08-09       Impact factor: 8.469

10.  Imatinib enhances functional outcome after spinal cord injury.

Authors:  Mathew B Abrams; Ingrid Nilsson; Sebastian A Lewandowski; Jacob Kjell; Simone Codeluppi; Lars Olson; Ulf Eriksson
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.